Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Grupo Espanol De Leucemia Mieloide Cronica (GELMC)

Spain Carre De Balmes 243 Escalera A 5º 1ª, 08006 Barcelona, Spain

About the sponsor

Grupo Espanol De Leucemia Mieloide Cronica (GELMC) focuses on BCR-ABL1-positive chronic myeloid leukemia, with interest in adult patients in the early chronic phase and treatment strategies aimed at deep molecular responses.

  • Asciminib in first-line therapy
  • Combination treatment with nilotinib
  • Deep molecular response and MR4
  • Early chronic phase disease management

The sponsor's clinical research activity is centered on therapeutic options for Philadelphia chromosome-positive leukemia across collaborative sites in Spain and other participating countries.

About Specializations

Grupo Espanol De Leucemia Mieloide Cronica (GELMC) runs clinical trials in conditions such as Chronic myeloid leukaemia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Chronic myeloid leukaemia

Recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ponatinib
  • Sponsor:Grupo Espanol De Leucemia Mieloide Cronica (GELMC)

Chronic myeloid leukaemia

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nilotinib
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.